KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Acquisitions (2016 - 2025)

Quest Diagnostics' Acquisitions history spans 12 years, with the latest figure at $300.0 million for Q3 2024.

  • For Q3 2024, Acquisitions changed N/A year-over-year to $300.0 million; the TTM value through Sep 2024 reached $300.0 million, changed N/A, while the annual FY2025 figure was $101.0 million, 95.33% down from the prior year.
  • Acquisitions for Q3 2024 was $300.0 million at Quest Diagnostics, up from $142.0 million in the prior quarter.
  • Across five years, Acquisitions topped out at $300.0 million in Q3 2024 and bottomed at $1.0 million in Q2 2022.
  • The 4-year median for Acquisitions is $108.0 million (2020), against an average of $113.1 million.
  • The largest YoY upside for Acquisitions was 80.2% in 2021 against a maximum downside of 80.2% in 2021.
  • A 4-year view of Acquisitions shows it stood at $101.0 million in 2020, then plummeted by 80.2% to $20.0 million in 2021, then plummeted by 95.0% to $1.0 million in 2022, then surged by 29900.0% to $300.0 million in 2024.
  • Per Business Quant, the three most recent readings for DGX's Acquisitions are $300.0 million (Q3 2024), $142.0 million (Q1 2024), and $1.0 million (Q2 2022).